Introduction
Epidemiological studies have reported an association between infections with certain bacterial or viral pathogens and the development of autoimmune diseases, including multiple sclerosis (MS) (Mills, 2011) . There is evidence that exacerbations of symptoms, and loss of neurological function in patients suffering from relapsing remitting MS often occur around the time of a clinical infections, most commonly upper respiratory infections (Turchinovich and Hayday, 2011). Furthermore, it has been suggested that systemic infections may trigger an increase in relapses in relapsing-remitting MS patients through bystander activation and sensitisation of auto-reactive myelin-specific T cells (Correale et al., 2006) . Chlamydia pneumonia infection is also associated with enhanced MRI spinal lesions in MS (Sotgiu et al., 2001) . Furthermore, the detection of Epstein Barr virus latent protein and herpes simplex virus in the brains of patients with MS has provided circumstantial evidence that pathogens may trigger or exacerbate the onset or progression of MS (Serafini et al., 2007) .
Conversely, the prevalence of human infections, especially with helminth parasites, has been linked with a reduced incidence and severity of allergic and autoimmune diseases, including MS. This has been explained by the 'hygiene hypothesis', whereby regulatory T (Treg) cells induced by helminths and possibly other pathogens can suppress Th2 and Th17 responses that mediate allergy and autoimmunity respectively (McSorley and Maizels, 2012) . Indeed it has been demonstrated that concurrent infection with helminths induced regression of new lesions and promoted remission in MS patients (Correale and Farez, 2007) . Studies in a murine model of MS, experimental autoimmune encephalomyelitis (EAE), have shown that infection with the helminth parasite Fasciola hepatica attenuated symptoms of EAE through TGF-b-mediated suppression of Th1 and Th17 responses (Walsh et al., 2009 ). The bacteria Staphyloccus aureus is also capable of suppressing EAE through an extracellular adherence protein, which has anti-inflammatory effects by binding to ICAM-1 and preventing the infiltration of myelin specific T cells across the blood brain barrier into the CNS (Waubant et al., 2001) .
